SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPinewood Technologies Group Regulatory News (PINE)

Share Price Information for Pinewood Technologies Group (PINE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    3.50 (1.45%)
Bid:
244.50
Ask:
246.50
Spread: 2.00 (0.818%)
Market Cap: £281.99m
PINE Live PriceLast checked at - London Stock Exchange

Intraday Pinewood Technologies Group Share Chart

Statement regarding Pinewood Technologies Group

13 Feb 2026 18:17

RNS Number : 0318T
Apax Partners LLP
13 February 2026
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

Β 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CODE.

Β 

FOR IMMEDIATE RELEASE

Β 

13 February 2026

Β 

Statement regarding Pinewood Technologies Group PLC ("Pinewood.AI" or the "Company")

Β 

On 29 January 2026, Pinewood.AI announced a possible cash offer for Pinewood.AI by Apax Partners LLP ("Apax").

Β 

In light of the prevailing challenging market conditions, Apax confirms that it does not intend to make an offer for the Company. Accordingly, Apax and any person acting in concert with it, except with the consent of the Panel on Takeovers and Mergers (the "Panel"), is bound by the restrictions under Rule 2.8 of the Code.

Β 

Apax, and any person acting in concert with Apax, reserves the right to announce an offer or possible offer for the Company or make or participate in an offer or possible offer for the Company and/or take any other action otherwise precluded under Rule 2.8 of the Code within six months of the date of this announcement in the following circumstances:

(i) with the agreement of the Board of Pinewood.AI;

(ii) if a third party announces a firm intention to make an offer for Pinewood.AI;

(iii) if Pinewood.AI announces a Rule 9 waiver proposal (see Note 1 of the Notes on Dispensations from Rule 9 of the Code) or a reverse takeover (as defined in the Code); and/or

(iv) if there has been a material change of circumstances (as determined by the Takeover Panel).

Β 

Enquiries:

Β 

Apax Partners LLP

Katarina Sallerfors

+44 20 7872 6300

Β 

Rule 26.1 Disclosure

Β 

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.apax.com, by no later than 12 noon (London time) on the business day following this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Β 

Further Information

Β 

This communication is not intended to and does not constitute an offer to buy or the solicitation of an offer to subscribe for or sell or an invitation to purchase or subscribe for any securities or the solicitation of any vote in any jurisdiction. The release, publication or distribution of this communication in whole or in part, directly or indirectly, in, into or from certain jurisdictions may be restricted by law and therefore persons in such jurisdictions should inform themselves about and observe such restrictions.

Β 

The distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdictions.

Β 

Β 

Β 

Β 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
OUPVXLFFQLLFBBX
Date   Source Headline
25th Sep 202512:13 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSHalf year results for the 6 months to 30 June 2025
15th Sep 20257:00 amRNSInclusion in FTSE 250 Index
11th Sep 20256:00 pmRNSWarehouse REIT
26th Aug 20255:26 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSHolding(s) in Company
4th Aug 202512:00 pmRNSCompletion of PWSA Business Acquisition
4th Aug 202511:41 amRNSHolding(s) in Company
4th Aug 20257:00 amRNSNotice of Interim Results
1st Aug 20259:00 amRNSHolding(s) in Company
31st Jul 20258:03 amRNSCompletion of Lithia JV Acquisition & Admission
30th Jul 20252:00 pmRNSAdmission of New Ordinary Shares
28th Jul 20257:00 amRNSAmendment of Acquisition Agreement
25th Jul 20253:35 pmRNSDirector/PDMR Shareholding
7th Jul 202511:28 amRNSDirector/PDMR Shareholding
7th Jul 20257:00 amRNSAcquisition of Pinewood South Africa Business
1st Jul 20253:23 pmRNSHolding(s) in Company
30th Jun 20254:10 pmRNSResults of AGM & General Meeting
27th Jun 20254:13 pmRNSDirector/PDMR Shareholding
12th Jun 20252:40 pmRNSDirector/PDMR Shareholding
6th Jun 20253:38 pmRNSPublication of Prospectus
6th Jun 20257:00 amRNSAcquisition of Lithia’s Stake in North America JV
4th Jun 202512:00 pmRNSBoard composition update
28th May 20257:00 amRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSignificant New Contract Award
28th Apr 20252:51 pmRNSDirector/PDMR Shareholding
17th Apr 202511:29 amRNSPublication of the Annual Report & Accounts FY24
1st Apr 20257:00 amRNSFinal Results
28th Mar 20259:00 amRNSDirector/PDMR Shareholding
28th Mar 20259:00 amRNSDirector Declaration
20th Mar 20254:24 pmRNSNotice of Results
3rd Mar 20252:00 pmRNSIssue of Seez Consideration Shares
27th Feb 20257:00 amRNSDirector/PDMR Shareholding
25th Feb 20251:54 pmRNSDirector/PDMR Shareholding
25th Feb 202512:00 pmRNS-RCommencement of Trading on OTCQX in the U.S.
21st Feb 20257:00 amRNSResult of Equity Fundraise
20th Feb 20254:40 pmRNSRetailBook Offer
20th Feb 20254:36 pmRNSEquity Fundraise
20th Feb 20254:35 pmRNSProposed Acquisition of Seez
14th Feb 20257:00 amRNSSignificant New Contract Award and Trading Update
12th Feb 202511:10 amRNSHolding(s) in Company
28th Jan 202512:09 pmRNSDirector/PDMR Shareholding
30th Dec 20247:00 amRNSPDMR Transaction Notification
20th Dec 20244:46 pmRNSHolding(s) in Company
26th Nov 202412:02 pmRNSDirector/PDMR Shareholding
22nd Nov 202411:45 amRNSDirector/PDMR Shareholding
15th Nov 202412:34 pmRNSHolding(s) in Company
5th Nov 20241:02 pmRNSDirector/PDMR Shareholding
1st Nov 20248:09 amRNSDirector/PDMR Shareholding
25th Oct 202411:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.